"10.1371_journal.pcbi.1000512","plos computational biology","2009-09-18T00:00:00Z","Rui-Ru Ji; Heshani de Silva; Yisheng Jin; Robert E Bruccoleri; Jian Cao; Aiqing He; Wenjun Huang; Paul S Kayne; Isaac M Neuhaus; Karl-Heinz Ott; Becky Penhallow; Mark I Cockett; Michael G Neubauer; Nathan O Siemers; Petra Ross-Macdonald","Bristol-Myers Squibb Research and Development, Princeton, New Jersey, United States of America; Johnson Graduate School of Management, Cornell University, Ithaca, New York, United States of America; Congenomics, Glastonbury, Connecticut, United States of America","Performed the experiments: HdS JC AH WH BP. Analyzed the data: RRJ YJ KHO PRM. Contributed reagents/materials/analysis tools: RRJ REB PSK IMN MIC NOS. Wrote the paper: RRJ PRM. Developed the analytical methods described in the manuscript: RRJ. Designed the experiments: HdS. Revised the manuscript: YJ REB KHO NOS. Conceived transcriptional dose response concept: MGN.","The authors are current and previous employees of Bristol-Myers Squibb, who is the manufacturer of dasatinib (one of the compounds included in the study).","2009","09","Rui-Ru Ji","RRJ",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
